Company intelligence / Profile preview

Support

Boston, Massachusetts, United States
Ownership
Private
Development stage
Other
01

Overview

Supportive Therapeutics is a Boston-based biotechnology company focused on developing innovative therapies for the supportive care of oncology patients. The company's primary mission is to address the side effects and complications associated with cancer treatments, such as chemotherapy and radiation. Its lead programs include small molecule candidates designed to improve the quality of life for patients undergoing intensive cancer therapy. By targeting unmet needs in supportive oncology, the company aims to reduce treatment-related morbidity and enhance patient adherence to primary cancer regimens.

Therapeutic areas
OncologyGastroenterology
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

ST-617

2

Beyond the preview

Go deeper on Support.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Support.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call